Abstract Introduction: Vismodegib (Erivedge, Genentech) is a first-in-class inhibitor of the hedgehog (Hh) pathway, which is licensed for use in locally

Orbital Schwannoma-Management and Clinical Outcomes Abstract Purpose: To evaluate the clinical features, management, and outcomes of orbital schwannomas. Methods: Retrospective study analyzing